Parathyroidectomy and heart rate variability in patients with stage 5 CKD

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 8, 2013, Pages 1378-1387

  Zhang, Jing ^a   Yu, Xiangbao ^a   Sun, Bin ^a   Bai, Jianling ^a   Wei, Yongyue ^a   Zha, Xiaoming ^b   Cui, Yiyao ^b   Zeng, Ming ^a   Zhang, Jingjing ^a   Liu, Jia ^a   Mao, Huijuan ^a   Zhang, Bo ^a   Ren, Haibin ^a   Ge, Yifei ^a   Xu, Xueqiang ^a   Shen, Zhixiang ^c   Xing, Changying ^a   Cao, Kejiang ^a   Wang, Ningning ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c Jiangsu Province Geriatric Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ADULT; ARTICLE; BLOOD EXAMINATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HEART RATE VARIABILITY; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; PROSPECTIVE STUDY;

ADULT; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEART RATE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; MIDDLE AGED; PARATHYROIDECTOMY; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84881235003     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.10381012     Document Type: Article

References (48)

1. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Guo H, Gustafson S, Heubner B, Lamb K, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, SheetsD,Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L: United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. AmJ Kidney Dis 59[1 Suppl 1]: e1-e420, 2012.
2. Goodman WG, Quarles LD: Development and progression of secondary hyperparathyroidism in chronic kidney disease: Lessons from molecular genetics. Kidney Int 74: 276-288, 2008.
3. Cunningham J, Locatelli F, Rodriguez M: Secondary hyperparathyroidism: Pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6: 913-921, 2011.
4. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G; Kidney Disease: Improving Global Outcomes (KDIGO): Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69: 1945-1953, 2006.
5. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004.
6. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780, 2006.
7. Moe SM, Drüeke TB: Management of secondary hyperparathyroidism: The importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product. Am J Nephrol 23: 369-379, 2003.
8. Raggi P, Kleerekoper M: Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease. Clin J Am Soc Nephrol 3: 836-843, 2008.
9. Kestenbaum B, Andress DL, Schwartz SM, Gillen DL, Seliger SL, Jadav PR, Sherrard DJ, Stehman-Breen C: Survival following parathyroidectomyamong United States dialysis patients. Kidney Int 66: 2010-2016, 2004.
10. Naranda J, Ekart R, Pecovnik-Balon B: Total parathyroidectomy with forearm autotransplantation as the treatment of choice for secondary hyperparathyroidism. J Int Med Res 39: 978-987, 2011.
11. Coen G, Calabria S, Bellinghieri G, Pecchini F, Conte F, Chiappini MG, Ferrannini M, Lagona C, Mallamace A, Manni M, DiLuca M, Sardella D, Taggi F: Parathyroidectomy in chronic renal failure: Short- and long-term results on parathyroid function, blood pressure and anemia. Nephron 88: 149-155, 2001.
12. Costa-Hong V, Jorgetti V, Gowdak LH, Moyses RM, Krieger EM, De Lima JJ: Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery 142: 699-703, 2007.
13. Chandra P, Sands RL, Gillespie BW, Levin NW, Kotanko P, Kiser M, Finkelstein F, Hinderliter A, Pop-Busui R, Rajagopalan S, Saran R: Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol Dial Transplant 27: 700-709, 2012.
14. Battipaglia I, Scalone G, Macchione A, Pinnacchio G, Laurito M, Milo M, Pelargonio G, Bencardino G, Bellocci F, Pieroni M, Lanza GA, Crea F: Association of heart rate variability with arrhythmic events in patientswith arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circ J 76: 618-623, 2012.
15. Fukuta H, Hayano J, Ishihara S, Sakata S, Mukai S, Ohte N, Ojika K, Yagi K, Matsumoto H, Sohmiya S, Kimura G: Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transplant 18: 318-325, 2003.
16. Oikawa K, Ishihara R, Maeda T, Yamaguchi K, Koike A, Kawaguchi H, Tabata Y, Murotani N, Itoh H: Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol 131: 370-377, 2009.
17. Wei CY, Chung TC, Wu SC, Chung CF, Wu WP: The subjective sleep quality and heart rate variability in hemodialysis patients. Ren Fail 33: 109-117, 2011.
18. Chan CT, Levin NW, Chertow GM, Larive B, Schulman G, Kotanko P; Frequent Hemodialysis Network Daily Trial Group: Determinants of cardiac autonomic dysfunction in ESRD. Clin J Am Soc Nephrol 5: 1821-1827, 2010.
19. Chan CT, Hanly P,Gabor J, Picton P, Pierratos A, Floras JS: Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 65: 661-665, 2004.
20. Steinberg AA, Mars RL, Goldman DS, Percy RF: Effect of endstage renal disease on decreased heart rate variability. Am J Cardiol 82: 1156-1158, 1998.
21. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[Suppl 3]: S1-S201, 2003.
22. Kojima M, Hayano J, Fukuta H, Sakata S, Mukai S, Ohte N, Seno H, Toriyama T, Kawahara H, Furukawa TA, Tokudome S: Loss of fractal heart rate dynamics in depressive hemodialysis patients. Psychosom Med 70: 177-185, 2008.
23. Roumelioti ME, Ranpuria R, Hall M, Hotchkiss JR, Chan CT, Unruh ML, Argyropoulos C: Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep. Nephrol Dial Transplant 25: 3733-3741, 2010.
24. Hayano J, Takahashi H, Toriyama T, Mukai S, Okada A, Sakata S, Yamada A, Ohte N, Kawahara H: Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant 14: 1480-1488, 1999.
25. Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD, Heiss G; Atherosclerosis Risk in Communities (ARIC) study: Diabetes, glucose, insulin, and heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 28: 668-674, 2005.
26. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17: 354-381, 1996.
27. Chan CT: Heart rate variability in patients with end-stage renal disease: An emerging predictive tool for sudden cardiac death? Nephrol Dial Transplant 23: 3061-3062, 2008.
28. Ranpuria R, Hall M, Chan CT, Unruh M: Heart rate variability (HRV) in kidney failure: Measurement and consequences of reduced HRV. Nephrol Dial Transplant 23: 444-449, 2008.
29. Yang YW, Wu CH, Tsai MK, Kuo TB, Yang CC, Lee PH: Heart rate variability during hemodialysis and following renal transplantation. Transplant Proc 42: 1637-1640, 2010.
30. Furuland H, Linde T, Englund A, Wikstrom B: Heart rate variability is decreased in chronic kidney disease but may improve with hemoglobin normalization. J Nephrol 21: 45-52, 2008.
31. Giordano M, Manzella D, Paolisso G, Caliendo A, Varricchio M, Giordano C: Differences in heart rate variability parameters during the post-dialytic period in type II diabetic and nondiabetic ESRD patients. Nephrol Dial Transplant 16: 566-573, 2001.
32. Kurata C, Uehara A, Sugi T, Ishikawa A, Fujita K, Yonemura K, Hishida A, Ishikawa K, Tawarahara K, Shouda S, Mikami T: Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 84: 312-319, 2000.
33. Deligiannis A, Kouidi E, Tourkantonis A: Effects of physical training on heart rate variability in patients on hemodialysis. AmJ Cardiol 84: 197-202, 1999.
34. Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and BoneDisorder (CKD-MBD). Kidney Int Suppl 113: S1-S130, 2009.
35. Martin KJ, Gonzalez EA: Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: What is normal, when to start, and how to treat? Clin J Am Soc Nephrol 6: 440-446, 2011.
36. Lishmanov A, Dorairajan S, Pak Y, Chaudhary K, Chockalingam A: Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease. Int Urol Nephrol 44: 541-547, 2012.
37. Nasri H, Baradaran A: Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Bratisl Lek Listy (Tlacene Vyd) 105: 368-373, 2004.
38. Akmal M, Barndt RR, Ansari AN, Mohler JG, Massry SG: Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy. Kidney Int 47: 158-163, 1995.
39. Grandi NC, Breitling LP, Hahmann H, Wüsten B, März W, Rothenbacher D, Brenner H: Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease. Heart 97: 1215-1221, 2011.
40. Perkovic V, Hunt D, Griffin SV, du Plessis M, Becker GJ: Accelerated progression of calcific aortic stenosis in dialysis patients. Nephron Clin Pract 94: c40-c45, 2003.
41. Peiris AN, Youssef D, Grant WB: Secondary hyperparathyroidism: Benign bystander or culpable contributor to adverse health outcomes? South Med J 105: 36-42, 2012.
42. Wanic-Kossowska M, Guzik P, Lehman P, Czekalski S: Heart rate variability in patients with chronic renal failure treated by hemodialysis. Pol Arch Med Wewn 114: 855-861, 2005.
43. Polak G, Strozecki P, Grześk G, Manitius J, Grabczewska Z, Przyby 248 R: Effect of parathormone on heart rate variability in hemodialysis patients. Auton Neurosci 115: 94-98, 2004.
44. Sharma J, Raggi P, Kutner N, Bailey J, Zhang R, Huang Y, Herzog CA, Weber C: Improved long-term survival of dialysis patients after near-total parathyroidectomy. J AmColl Surg 214: 400-407, 2012.
45. Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y: Impact of parathyroidectomy on renal graft function, blood pressure and serumlipids in kidney transplant recipients: Asingle centre study. Nephrol Dial Transplant 20: 1714-1720, 2005.
46. Zouboulis CC, Blume-Peytavi U, Lennert T, Stavropoulos PG, Schwarz A, Runkel N, Trautmann C, Orfanos CE: Fulminant metastatic calcinosis with cutaneous necrosis in a childwith endstage renal disease and tertiary hyperparathyroidism. Br J Dermatol 135: 617-622, 1996.
47. Goldsmith DJ, Covic A, Sambrook PA, Ackrill P: Vascular calcification in long-term haemodialysis patients in a single unit: A retrospective analysis. Nephron 77: 37-43, 1997.
48. Chow KM, Szeto CC, Kum LC, Kwan BC, Fung TM, Wong TY, Leung CB, Li PK: Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy. J Nephrol 16: 878-885, 2003